HLHuan Li

Huan Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Huan Li has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perioperative Body-Composition and Phase-Angle Measures in Women Undergoing Breast Cancer Surgery After Neoadjuvant Chemotherapy or Treated Through a Surgery-First Pathway (BC-NUTRITION): Exploratory 2-Cohort Pilot Analysis

    by Yu Liu, Congyi Ma, Guanfeng Chen, WangJing Hu, Lu Li, Jingxia Pan, Huan Li

    Background: Breast cancer survivorship requires attention to treatment-related changes in body composition, nutritional status, and quality of life. Bioelectrical impedance phase angle is influenced by tissue electrical properties and fluid distribution and may provide complementary whole-body and segmental information. Objective: This study described perioperative body-composition and phase-angle measures in women undergoing breast cancer surgery after neoadjuvant chemotherapy or treated through a surgery-first pathway. It also estimated T0-to-T2 changes and documented the availability of selected longitudinal variables. Methods: BC-NUTRITION (Body Composition and Nutrition Trajectories in Breast Cancer) is a prospective 2-cohort observational study with 5 planned assessments from admission to 6 months after discharge. The present exploratory pilot analysis included 30 women in cohort A, assessed after neoadjuvant chemotherapy, and 65 women in cohort B, who were treated through a surgery-first pathway. T1 measurements were displayed descriptively; inferential analyses used T0 values and participant-level T0-to-T2 changes. T0 between-cohort comparisons used Welch 2-sample t tests, within-cohort changes used paired t tests, and between-cohort differences in change used Welch tests. Benjamini-Hochberg q values were calculated across the 13 between-cohort change comparisons. Results: All 95 participants had complete data for the 13 selected longitudinal variables at T0, T1, and T2. At T0, cohort A had lower albumin, absolute lymphocyte count, prognostic nutritional index, and whole-body 50-kHz phase angle. The whole-body phase-angle means were 4.64° (SD 0.66) and 5.23° (SD 0.62), with a difference of −0.59° (95% CI −0.88° to −0.31°; P <.001). Cohort A had a higher whole-body extracellular water to total body water ratio (ECW/TBW) than cohort B (0.3890 vs 0.3815; P <.001). Ipsilateral upper-limb 50-kHz phase angle changed by −0.50° in cohort A and −0.51° in cohort B between T0 and T2. The between-cohort difference was 0.01° (95% CI −0.17° to 0.19°; P =.93). The corresponding difference in whole-body phase-angle change was 0.14° (95% CI −0.02° to 0.30°; P =.09). No q value for the 13 between-cohort change comparisons was below 0.05. Conclusions: The treatment pathways differed in selected laboratory and whole-body bioelectrical measures at T0. The mean upper-limb phase angle ipsilateral to the recorded tumor side decreased in both cohorts between T0 and T2. All five prespecified perioperative feasibility thresholds were met in the available T0-to-T2 data. Assessment acceptability and T3/T4 follow-up were not evaluated. Definitive interpretation requires standardized acquisition, a prechemotherapy baseline, relevant clinical covariates, and outpatient follow-up.

  • Open Access

    Development and Validation of a New Multiparametric Random Survival Forest Predictive Model for Breast Cancer Recurrence with a Potential Benefit to Individual Outcomes

    by Huan Li, Ren-Bin Liu, Chen-Meng Long, Yuan Teng, Lin Cheng, Yu Liu

    Purpose: Breast cancer (BC) is a multi-factorial disease. Its individual prognosis varies; thus, individualized patient profiling is instrumental to improving BC management and individual outcomes. An economical, multiparametric, and practical model to predict BC recurrence is needed. Patients and Methods: We retrospectively investigated the clinical data of BC patients treated at the Third Affiliated Hospital of Sun Yat-sen University and Liuzhou Women and Children’s Medical Center from January 2013 to December 2020. Random forest-recursive feature elimination (run by R caret package) was used to determine the best variable set, and the random survival forest method was used to develop a predictive model for BC recurrence. Results: The training and validations sets included 623 and 151 patients, respectively. We selected 14 variables, the pathological (TNM) stage, gamma-glutamyl transpeptidase, total cholesterol, Ki-67, lymphocyte count, low-density lipoprotein, age, apolipoprotein B, high-density lipoprotein, globulin, neutrophil count to lymphocyte count ratio, alanine aminotransferase, triglyceride, and albumin to globulin ratio, using random survival forest (RSF)-recursive feature elimination. We developed a recurrence prediction model using RSF. Using area under the receiver operating characteristic curve and Kaplan–Meier survival analyses, the model performance was determined to be accurate. C-indexes were 0.997 and 0.936 for the training and validation sets, respectively. Conclusion: The model could accurately predict BC recurrence. It aids clinicians in identifying high-risk patients and making treatment decisions for Breast cancer patients in China. This new multiparametric RSF model is instrumental for breast cancer recurrence prediction and potentially improves individual outcomes.